Physician

Matthew James Baker, MD

According to 2025 Medicare claims, Matthew Baker, MD (NPI: 1154372167) practices neurology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is COLLIER NEUROLOGIC SPECIALISTS LLC (NPI: 1871543512; TIN: 59-3454890) and primary practice location at 34105-8523. Baker is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Baker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 609 traditional Medicare patients, billed 67,711 HCPCS/CPT codes, and received $3,358,015 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,710 prescription claims across 502 beneficiaries totaling $4,802,338 in drug costs, led by Copaxone (Glatiramer Acetate). 2023 DME data shows 70 claims. Open Payments data shows 401 records totaling $1,049,734. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $224,436 to $3,358,015. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $24,082 and ending at $50,305.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $224,436 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $208,317 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $211,914 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $720,153 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,303,507 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,941,837 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,021,675 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,701,593 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,880,519 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,358,015 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158463,513$224,436
20168294,106$208,317
20178126,031$211,914
201886717,120$720,153
201974446,094$2,303,507
202071150,553$2,941,837
202170956,480$3,021,675
202265746,172$2,701,593
202360148,875$2,880,519
202460967,711$3,358,015

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.3M$8.7M2015 Drug cost: $6,032,902 (USD; Tot_Drug_Cst)2016 Drug cost: $7,483,670 (USD; Tot_Drug_Cst)2017 Drug cost: $7,885,377 (USD; Tot_Drug_Cst)2018 Drug cost: $8,688,093 (USD; Tot_Drug_Cst)2019 Drug cost: $8,183,444 (USD; Tot_Drug_Cst)2020 Drug cost: $7,900,015 (USD; Tot_Drug_Cst)2021 Drug cost: $6,900,716 (USD; Tot_Drug_Cst)2022 Drug cost: $5,770,779 (USD; Tot_Drug_Cst)2023 Drug cost: $5,423,902 (USD; Tot_Drug_Cst)2024 Drug cost: $4,802,338 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155015,326$6,032,902
20165245,701$7,483,670
20175125,003$7,885,377
20185194,740$8,688,093
20195965,712$8,183,444
20205855,863$7,900,015
20216245,735$6,900,716
20225705,362$5,770,779
20235314,734$5,423,902
20245024,710$4,802,338

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$65K$130K2016 Medicare payment: $637 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $343 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $113,170 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $129,542 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R11$637
2017N/RN/RN/R
2018N/R12$343
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R60$113,170
2023N/R70$129,542
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more446766$135
96413Administration of chemotherapy into vein, 1 hour or less44150$98
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more253385$90
70553Mri scan of brain before and after contrast4646$85
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes43381$63

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CopaxoneGlatiramer Acetate872,626$505,377
AubagioTeriflunomide391,530$459,379
ZeposiaOzanimod Hydrochloride381,380$405,669
Avonex Pen (4 Pack)Interferon Beta-1a25700$211,560
VumerityDiroximel Fumarate17510$142,748

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.368$215,912EMD Serono, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.33$833,822Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew James Baker, MD?

Tedicare shows public-source Medicare data for Matthew James Baker, MD (NPI 1154372167), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew James Baker, MD have ACO affiliation data?

Matthew James Baker, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Matthew James Baker, MD?

Matthew James Baker, MD is linked to COLLIER NEUROLOGIC SPECIALISTS LLC (billing NPI 1871543512) in the available physician profile data.

Does Matthew James Baker, MD have Open Payments data?

Matthew James Baker, MD has 401 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.